Dorsa Pharmaceutical

Dorsa Pharmaceutical is a prominent Iranian pharmaceutical manufacturer established in 1997, specializing in the development and production of high-quality finished dosage forms. The company maintains a diverse portfolio focusing on several key therapeutic areas, including central nervous system (CNS) disorders, cardiovascular health, and nutritional supplements. Dorsa is particularly recognized for its advanced manufacturing capabilities in solid dosage forms, such as tablets, capsules, and soft gels, all produced under strict international Good Manufacturing Practice (GMP) standards. With a robust research and development department, the company continuously expands its product line to include both generic and branded medications aimed at addressing chronic health conditions. Dorsa Pharmaceutical serves a significant portion of the domestic Iranian market while also pursuing regional export opportunities in the Middle East.